United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News AriBio gets exclusive marketing rights in China for Alzheimer’s candidate AR1001 in $770m deal In a significant stride towards addressing early Alzheimer’s disease, AriBio Co., Ltd. (AriBio) has announced an exclusive agreement… byPallavi MadhirajuMarch 25, 2024